108 related articles for article (PubMed ID: 16900015)
1. Prevention of myocardial infarction.
Gurfinkel EP; Lernoud VS
Curr Opin Cardiol; 2006 Sep; 21(5):503-9. PubMed ID: 16900015
[TBL] [Abstract][Full Text] [Related]
2. Prevention of heart failure.
Bansal D; Chahoud G; Smith ES; Mehta JL
Curr Opin Cardiol; 2006 Sep; 21(5):510-6. PubMed ID: 16900016
[TBL] [Abstract][Full Text] [Related]
3. The altered homeostatic theory: A hypothesis proposed to be useful in understanding and preventing ischemic heart disease, hypertension, and diabetes--including reducing the risk of age and atherosclerosis.
Hellstrom HR
Med Hypotheses; 2007; 68(2):415-33. PubMed ID: 16828234
[TBL] [Abstract][Full Text] [Related]
4. A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction.
Lamotte M; Annemans L; Kawalec P; Zoellners Y
Herz; 2006 Dec; 31 Suppl 3():74-82. PubMed ID: 17575809
[TBL] [Abstract][Full Text] [Related]
5. [Reduction of cholesterol and myocardial infarction. Big differences between different groups when it comes to the therapeutic effect].
Håkansson J
Lakartidningen; 1997 Dec; 94(49):4619, 4622-3. PubMed ID: 9445934
[No Abstract] [Full Text] [Related]
6. Oxidative stress as the leading cause of acute myocardial infarction in diabetics.
Di Filippo C; Cuzzocrea S; Rossi F; Marfella R; D'Amico M
Cardiovasc Drug Rev; 2006; 24(2):77-87. PubMed ID: 16961722
[TBL] [Abstract][Full Text] [Related]
7. The things to come of SHAPE: cost and effectiveness of cardiovascular prevention.
Diamond GA; Kaul S
Am J Cardiol; 2007 Apr; 99(7):1013-5. PubMed ID: 17398203
[TBL] [Abstract][Full Text] [Related]
8. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
9. Is an invasive interventional strategy of value in non-ST-elevation acute coronary syndromes?
Weintraub WS
Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):754-5. PubMed ID: 18838964
[TBL] [Abstract][Full Text] [Related]
10. Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young".
Migliaresi P; Celentano A; Palmieri V; Pezzullo S; Martino S; Bonito M; Guillaro B; Brancati C; Di Minno G
Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):468-72. PubMed ID: 17379491
[TBL] [Abstract][Full Text] [Related]
11. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.
Chan PS; Nallamothu BK; Gurm HS; Hayward RA; Vijan S
Circulation; 2007 May; 115(18):2398-409. PubMed ID: 17452609
[TBL] [Abstract][Full Text] [Related]
12. Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction.
Norata GD; Ongari M; Garlaschelli K; Tibolla G; Grigore L; Raselli S; Vettoretti S; Baragetti I; Noto D; Cefalù AB; Buccianti G; Averna M; Catapano AL
J Intern Med; 2007 Jul; 262(1):104-12. PubMed ID: 17598818
[TBL] [Abstract][Full Text] [Related]
13. [How I treat and manage cholesterol after myocardial infarction].
Capron L
Journ Annu Diabetol Hotel Dieu; 1996; ():199-209. PubMed ID: 8965423
[No Abstract] [Full Text] [Related]
14. Psychosocial and behavioral aspects of cardiovascular disease prevention in men and women.
Orth-Gomér K
Curr Opin Psychiatry; 2007 Mar; 20(2):147-51. PubMed ID: 17278913
[TBL] [Abstract][Full Text] [Related]
15. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
[TBL] [Abstract][Full Text] [Related]
16. Association of gene polymorphisms with myocardial infarction in individuals with or without conventional coronary risk factors.
Nishihama K; Yamada Y; Matsuo H; Segawa T; Watanabe S; Kato K; Yajima K; Hibino T; Yokoi K; Ichihara S; Metoki N; Yoshida H; Satoh K; Nozawa Y
Int J Mol Med; 2007 Jan; 19(1):129-41. PubMed ID: 17143557
[TBL] [Abstract][Full Text] [Related]
17. Genetic risk for atherothrombotic cerebral infarction in individuals stratified by sex or conventional risk factors for atherosclerosis.
Yamaguchi S; Yamada Y; Metoki N; Yoshida H; Satoh K; Ichihara S; Kato K; Kameyama T; Yokoi K; Matsuo H; Segawa T; Watanabe S; Nozawa Y
Int J Mol Med; 2006 Nov; 18(5):871-83. PubMed ID: 17016617
[TBL] [Abstract][Full Text] [Related]
18. Highly purified omega-3 polyunsaturated fatty acids are effective as adjunct therapy for secondary prevention of myocardial infarction.
Verboom CN;
Herz; 2006 Dec; 31 Suppl 3():49-59. PubMed ID: 17575805
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for atherosclerotic disease: present and future.
Vinereanu D
Herz; 2006 Dec; 31 Suppl 3():5-24. PubMed ID: 17577934
[TBL] [Abstract][Full Text] [Related]
20. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
